カテゴリー： LP Information, 世界, 医療/バイオ

世界の予防可能ワクチン市場予測 2021年-2026年

【英語タイトル】Global Preventable Vaccines Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9555）・商品コード：LPI21MY9555
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：177
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「予防可能ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、成人用予防可能ワクチン、小児用予防可能ワクチンなど、用途別には、細菌感染症、ウイルス病などにセグメント区分してまとめました。予防可能ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・予防可能ワクチンの世界市場概要（サマリー）
・予防可能ワクチンの企業別販売量・売上
・予防可能ワクチンの企業別市場シェア
・予防可能ワクチンの世界市場規模 2016年-2021年：種類別（成人用予防可能ワクチン、小児用予防可能ワクチン）
・予防可能ワクチンの世界市場規模 2016年-2021年：用途別（細菌感染症、ウイルス病）
・予防可能ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・予防可能ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・予防可能ワクチンのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・予防可能ワクチンの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・予防可能ワクチン市場の成長要因・課題・動向
・予防可能ワクチンの世界市場予測 2021年-2026年
・予防可能ワクチンの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・予防可能ワクチンのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・予防可能ワクチンのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・予防可能ワクチンの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・予防可能ワクチンの世界市場予測：種類別（成人用予防可能ワクチン、小児用予防可能ワクチン）
・予防可能ワクチンの世界市場予測：用途別（細菌感染症、ウイルス病）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Preventable Vaccines will have significant change from previous year. By the most conservative estimates of global Preventable Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Preventable Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Preventable Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Adult Preventable Vaccines
Pediatric Preventable Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Bacterial Diseases
Virus Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preventable Vaccines Consumption 2016-2026
2.1.2 Preventable Vaccines Consumption CAGR by Region
2.2 Preventable Vaccines Segment by Type
2.2.1 Adult Preventable Vaccines
2.2.2 Pediatric Preventable Vaccines
2.3 Preventable Vaccines Sales by Type
2.3.1 Global Preventable Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global Preventable Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global Preventable Vaccines Sale Price by Type (2016-2021)
2.4 Preventable Vaccines Segment by Application
2.4.1 Bacterial Diseases
2.4.2 Virus Diseases
2.5 Preventable Vaccines Sales by Application
2.5.1 Global Preventable Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global Preventable Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global Preventable Vaccines Sale Price by Application (2016-2021)

3 Global Preventable Vaccines by Company
3.1 Global Preventable Vaccines Sales Market Share by Company
3.1.1 Global Preventable Vaccines Sales by Company (2019-2021)
3.1.2 Global Preventable Vaccines Sales Market Share by Company (2019-2021)
3.2 Global Preventable Vaccines Revenue Market Share by Company
3.2.1 Global Preventable Vaccines Revenue by Company (2019-2021)
3.2.2 Global Preventable Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global Preventable Vaccines Sale Price by Company
3.4 Global Manufacturers Preventable Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventable Vaccines Product Location Distribution
3.4.2 Players Preventable Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Preventable Vaccines by Region
4.1 Global Preventable Vaccines by Region
4.1.1 Global Preventable Vaccines Sales by Region
4.1.2 Global Preventable Vaccines Revenue by Region
4.2 Americas Preventable Vaccines Sales Growth
4.3 APAC Preventable Vaccines Sales Growth
4.4 Europe Preventable Vaccines Sales Growth
4.5 Middle East & Africa Preventable Vaccines Sales Growth

5 Americas
5.1 Americas Preventable Vaccines Sales by Country
5.1.1 Americas Preventable Vaccines Sales by Country (2016-2021)
5.1.2 Americas Preventable Vaccines Revenue by Country (2016-2021)
5.2 Americas Preventable Vaccines Sales by Type
5.3 Americas Preventable Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Preventable Vaccines Sales by Region
6.1.1 APAC Preventable Vaccines Sales by Region (2016-2021)
6.1.2 APAC Preventable Vaccines Revenue by Region (2016-2021)
6.2 APAC Preventable Vaccines Sales by Type
6.3 APAC Preventable Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Preventable Vaccines by Country
7.1.1 Europe Preventable Vaccines Sales by Country (2016-2021)
7.1.2 Europe Preventable Vaccines Revenue by Country (2016-2021)
7.2 Europe Preventable Vaccines Sales by Type
7.3 Europe Preventable Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Preventable Vaccines by Country
8.1.1 Middle East & Africa Preventable Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa Preventable Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa Preventable Vaccines Sales by Type
8.3 Middle East & Africa Preventable Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Preventable Vaccines Distributors
10.3 Preventable Vaccines Customer

11 Global Preventable Vaccines Market Forecast
11.1 Global Preventable Vaccines Forecast by Region
11.1.1 Global Preventable Vaccines Forecast by Regions (2021-2026)
11.2.2 Global Preventable Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Preventable Vaccines Forecast by Type
11.7 Global Preventable Vaccines Forecast by Application

12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Preventable Vaccines Product Offered
12.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Preventable Vaccines Product Offered
12.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Preventable Vaccines Product Offered
12.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Preventable Vaccines Product Offered
12.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Sanofi
12.5.1 Sanofi Company Information
12.5.2 Sanofi Preventable Vaccines Product Offered
12.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sanofi Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Takeda Pharmaceutical
12.6.1 Takeda Pharmaceutical Company Information
12.6.2 Takeda Pharmaceutical Preventable Vaccines Product Offered
12.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Takeda Pharmaceutical Main Business Overview
12.6.5 Takeda Pharmaceutical Latest Developments
12.7 Abbott
12.7.1 Abbott Company Information
12.7.2 Abbott Preventable Vaccines Product Offered
12.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Abbott Main Business Overview
12.7.5 Abbott Latest Developments
12.8 Roche
12.8.1 Roche Company Information
12.8.2 Roche Preventable Vaccines Product Offered
12.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Roche Main Business Overview
12.8.5 Roche Latest Developments
12.9 AstraZeneca
12.9.1 AstraZeneca Company Information
12.9.2 AstraZeneca Preventable Vaccines Product Offered
12.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 AstraZeneca Main Business Overview
12.9.5 AstraZeneca Latest Developments
12.10 Mitsubishi Tanabe Pharma
12.10.1 Mitsubishi Tanabe Pharma Company Information
12.10.2 Mitsubishi Tanabe Pharma Preventable Vaccines Product Offered
12.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Mitsubishi Tanabe Pharma Main Business Overview
12.10.5 Mitsubishi Tanabe Pharma Latest Developments
12.11 Lupin
12.11.1 Lupin Company Information
12.11.2 Lupin Preventable Vaccines Product Offered
12.11.3 Lupin Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Lupin Main Business Overview
12.11.5 Lupin Latest Developments
12.12 Serum Institute of India
12.12.1 Serum Institute of India Company Information
12.12.2 Serum Institute of India Preventable Vaccines Product Offered
12.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Serum Institute of India Main Business Overview
12.12.5 Serum Institute of India Latest Developments
12.13 LG Life Sciences
12.13.1 LG Life Sciences Company Information
12.13.2 LG Life Sciences Preventable Vaccines Product Offered
12.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 LG Life Sciences Main Business Overview
12.13.5 LG Life Sciences Latest Developments
12.14 S K Chemicals
12.14.1 S K Chemicals Company Information
12.14.2 S K Chemicals Preventable Vaccines Product Offered
12.14.3 S K Chemicals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 S K Chemicals Main Business Overview
12.14.5 S K Chemicals Latest Developments
12.15 Shenzhen Kangtai Biological Products
12.15.1 Shenzhen Kangtai Biological Products Company Information
12.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Product Offered
12.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Shenzhen Kangtai Biological Products Main Business Overview
12.15.5 Shenzhen Kangtai Biological Products Latest Developments
12.16 Sinovac Biotech
12.16.1 Sinovac Biotech Company Information
12.16.2 Sinovac Biotech Preventable Vaccines Product Offered
12.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Sinovac Biotech Main Business Overview
12.16.5 Sinovac Biotech Latest Developments
12.17 Janssen Pharmaceuticals
12.17.1 Janssen Pharmaceuticals Company Information
12.17.2 Janssen Pharmaceuticals Preventable Vaccines Product Offered
12.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Janssen Pharmaceuticals Main Business Overview
12.17.5 Janssen Pharmaceuticals Latest Developments
12.18 Crucell
12.18.1 Crucell Company Information
12.18.2 Crucell Preventable Vaccines Product Offered
12.18.3 Crucell Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Crucell Main Business Overview
12.18.5 Crucell Latest Developments
12.19 Bavarian Nordic
12.19.1 Bavarian Nordic Company Information
12.19.2 Bavarian Nordic Preventable Vaccines Product Offered
12.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Bavarian Nordic Main Business Overview
12.19.5 Bavarian Nordic Latest Developments
12.20 Baxter
12.20.1 Baxter Company Information
12.20.2 Baxter Preventable Vaccines Product Offered
12.20.3 Baxter Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Baxter Main Business Overview
12.20.5 Baxter Latest Developments
12.21 Bharat Biotech
12.21.1 Bharat Biotech Company Information
12.21.2 Bharat Biotech Preventable Vaccines Product Offered
12.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Bharat Biotech Main Business Overview
12.21.5 Bharat Biotech Latest Developments
12.22 Dynavax
12.22.1 Dynavax Company Information
12.22.2 Dynavax Preventable Vaccines Product Offered
12.22.3 Dynavax Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 Dynavax Main Business Overview
12.22.5 Dynavax Latest Developments
12.23 Bausch Health
12.23.1 Bausch Health Company Information
12.23.2 Bausch Health Preventable Vaccines Product Offered
12.23.3 Bausch Health Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.23.4 Bausch Health Main Business Overview
12.23.5 Bausch Health Latest Developments
12.24 Protein Sciences
12.24.1 Protein Sciences Company Information
12.24.2 Protein Sciences Preventable Vaccines Product Offered
12.24.3 Protein Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.24.4 Protein Sciences Main Business Overview
12.24.5 Protein Sciences Latest Developments
12.25 Panacea Biotec
12.25.1 Panacea Biotec Company Information
12.25.2 Panacea Biotec Preventable Vaccines Product Offered
12.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.25.4 Panacea Biotec Main Business Overview
12.25.5 Panacea Biotec Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Preventable Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Adult Preventable Vaccines
Table 3. Major Players of Pediatric Preventable Vaccines
Table 4. Global Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 5. Global Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 6. Global Preventable Vaccines Revenue by Type (2016-2021) & ($ million)
Table 7. Global Preventable Vaccines Revenue Market Share by Type (2016-2021)
Table 8. Global Preventable Vaccines Sale Price by Type (2016-2021)
Table 9. Global Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 10. Global Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 11. Global Preventable Vaccines Value by Application (2016-2021)
Table 12. Global Preventable Vaccines Revenue Market Share by Application (2016-2021)
Table 13. Global Preventable Vaccines Sale Price by Application (2016-2021)
Table 14. Global Preventable Vaccines Sales by Company (2019-2021) & (K Units)
Table 15. Global Preventable Vaccines Sales Market Share by Company (2019-2021)
Table 16. Global Preventable Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Preventable Vaccines Revenue Market Share by Company (2019-2021)
Table 18. Global Preventable Vaccines Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Preventable Vaccines Producing Area Distribution and Sales Area
Table 20. Players Preventable Vaccines Products Offered
Table 21. Preventable Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Preventable Vaccines Sales by Region (2016-2021) (K Units)
Table 25. Global Preventable Vaccines Sales Market Share by Region (2016-2021)
Table 26. Global Preventable Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Preventable Vaccines Revenue Market Share by Region (2016-2021)
Table 28. Americas Preventable Vaccines Sales by Country (2016-2021) & (K Units)
Table 29. Americas Preventable Vaccines Sales Market Share by Country (2016-2021)
Table 30. Americas Preventable Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Preventable Vaccines Revenue Market Share by Country (2016-2021)
Table 32. Americas Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 33. Americas Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 34. Americas Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 35. Americas Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 36. APAC Preventable Vaccines Sales by Region (2016-2021) & (K Units)
Table 37. APAC Preventable Vaccines Sales Market Share by Region (2016-2021)
Table 38. APAC Preventable Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Preventable Vaccines Revenue Market Share by Region (2016-2021)
Table 40. APAC Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 41. APAC Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 42. APAC Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 43. APAC Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 44. Europe Preventable Vaccines Sales by Country (2016-2021) & (K Units)
Table 45. Europe Preventable Vaccines Sales Market Share by Country (2016-2021)
Table 46. Europe Preventable Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Preventable Vaccines Revenue Market Share by Country (2016-2021)
Table 48. Europe Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 49. Europe Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 50. Europe Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 51. Europe Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Preventable Vaccines Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Preventable Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 60. Global Preventable Vaccines Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Preventable Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Preventable Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Preventable Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Preventable Vaccines Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Preventable Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Preventable Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Preventable Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 68. GlaxoSmithKline Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 69. GlaxoSmithKline Preventable Vaccines Product Offered
Table 70. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. GlaxoSmithKline Main Business
Table 72. GlaxoSmithKline Latest Developments
Table 73. Merck Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Preventable Vaccines Product Offered
Table 75. Merck Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Novartis Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Preventable Vaccines Product Offered
Table 80. Novartis Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Pfizer Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Preventable Vaccines Product Offered
Table 85. Pfizer Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Sanofi Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Preventable Vaccines Product Offered
Table 90. Sanofi Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Takeda Pharmaceutical Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Takeda Pharmaceutical Preventable Vaccines Product Offered
Table 95. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Takeda Pharmaceutical Main Business
Table 97. Takeda Pharmaceutical Latest Developments
Table 98. Abbott Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Preventable Vaccines Product Offered
Table 100. Abbott Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. Roche Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Preventable Vaccines Product Offered
Table 105. Roche Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. AstraZeneca Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca Preventable Vaccines Product Offered
Table 110. AstraZeneca Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Mitsubishi Tanabe Pharma Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Mitsubishi Tanabe Pharma Preventable Vaccines Product Offered
Table 115. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Mitsubishi Tanabe Pharma Main Business
Table 117. Mitsubishi Tanabe Pharma Latest Developments
Table 118. Lupin Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Lupin Preventable Vaccines Product Offered
Table 120. Lupin Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Lupin Main Business
Table 122. Lupin Latest Developments
Table 123. Serum Institute of India Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Serum Institute of India Preventable Vaccines Product Offered
Table 125. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Serum Institute of India Main Business
Table 127. Serum Institute of India Latest Developments
Table 128. LG Life Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. LG Life Sciences Preventable Vaccines Product Offered
Table 130. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. LG Life Sciences Main Business
Table 132. LG Life Sciences Latest Developments
Table 133. S K Chemicals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. S K Chemicals Preventable Vaccines Product Offered
Table 135. S K Chemicals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. S K Chemicals Main Business
Table 137. S K Chemicals Latest Developments
Table 138. Shenzhen Kangtai Biological Products Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Shenzhen Kangtai Biological Products Preventable Vaccines Product Offered
Table 140. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Shenzhen Kangtai Biological Products Main Business
Table 142. Shenzhen Kangtai Biological Products Latest Developments
Table 143. Sinovac Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Sinovac Biotech Preventable Vaccines Product Offered
Table 145. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. Sinovac Biotech Main Business
Table 147. Sinovac Biotech Latest Developments
Table 148. Janssen Pharmaceuticals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Janssen Pharmaceuticals Preventable Vaccines Product Offered
Table 150. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. Janssen Pharmaceuticals Main Business
Table 152. Janssen Pharmaceuticals Latest Developments
Table 153. Crucell Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Crucell Preventable Vaccines Product Offered
Table 155. Crucell Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 156. Crucell Main Business
Table 157. Crucell Latest Developments
Table 158. Bavarian Nordic Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Bavarian Nordic Preventable Vaccines Product Offered
Table 160. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 161. Bavarian Nordic Main Business
Table 162. Bavarian Nordic Latest Developments
Table 163. Baxter Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Baxter Preventable Vaccines Product Offered
Table 165. Baxter Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 166. Baxter Main Business
Table 167. Baxter Latest Developments
Table 168. Bharat Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Bharat Biotech Preventable Vaccines Product Offered
Table 170. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 171. Bharat Biotech Main Business
Table 172. Bharat Biotech Latest Developments
Table 173. Dynavax Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Dynavax Preventable Vaccines Product Offered
Table 175. Dynavax Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 176. Dynavax Main Business
Table 177. Dynavax Latest Developments
Table 178. Bausch Health Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Bausch Health Preventable Vaccines Product Offered
Table 180. Bausch Health Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 181. Bausch Health Main Business
Table 182. Bausch Health Latest Developments
Table 183. Protein Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Protein Sciences Preventable Vaccines Product Offered
Table 185. Protein Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 186. Protein Sciences Main Business
Table 187. Protein Sciences Latest Developments
Table 188. Panacea Biotec Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Panacea Biotec Preventable Vaccines Product Offered
Table 190. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 191. Panacea Biotec Main Business
Table 192. Panacea Biotec Latest Developments
List of Figures
Figure 1. Picture of Preventable Vaccines
Figure 2. Preventable Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventable Vaccines Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Preventable Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Preventable Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Adult Preventable Vaccines
Figure 10. Product Picture of Pediatric Preventable Vaccines
Figure 11. Global Preventable Vaccines Sales Market Share by Type in 2020
Figure 12. Global Preventable Vaccines Revenue Market Share by Type (2016-2021)
Figure 13. Preventable Vaccines Consumed in Bacterial Diseases
Figure 14. Global Preventable Vaccines Market: Bacterial Diseases (2016-2021) & (K Units)
Figure 15. Preventable Vaccines Consumed in Virus Diseases
Figure 16. Global Preventable Vaccines Market: Virus Diseases (2016-2021) & (K Units)
Figure 17. Global Preventable Vaccines Sales Market Share by Application (2016-2021)
Figure 18. Global Preventable Vaccines Revenue Market Share by Application in 2020
Figure 19. Global Preventable Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Preventable Vaccines Revenue Market Share by Company in 2020
Figure 21. Global Preventable Vaccines Sales Market Share by Regions (2016-2021)
Figure 22. Global Preventable Vaccines Revenue Market Share by Region in 2020
Figure 23. Americas Preventable Vaccines Sales 2016-2021 (K Units)
Figure 24. Americas Preventable Vaccines Revenue 2016-2021 ($ Millions)
Figure 25. APAC Preventable Vaccines Sales 2016-2021 (K Units)
Figure 26. APAC Preventable Vaccines Revenue 2016-2021 ($ Millions)
Figure 27. Europe Preventable Vaccines Sales 2016-2021 (K Units)
Figure 28. Europe Preventable Vaccines Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Preventable Vaccines Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Preventable Vaccines Revenue 2016-2021 ($ Millions)
Figure 31. Americas Preventable Vaccines Sales Market Share by Country in 2020
Figure 32. Americas Preventable Vaccines Revenue Market Share by Country in 2020
Figure 33. Americas Preventable Vaccines Sales Market Share by Type in 2020
Figure 34. Americas Preventable Vaccines Sales Market Share by Application in 2020
Figure 35. United States Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Preventable Vaccines Sales Market Share by Region in 2020
Figure 40. APAC Preventable Vaccines Revenue Market Share by Regions in 2020
Figure 41. APAC Preventable Vaccines Sales Market Share by Type in 2020
Figure 42. APAC Preventable Vaccines Sales Market Share by Application in 2020
Figure 43. China Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Preventable Vaccines Sales Market Share by Country in 2020
Figure 50. Europe Preventable Vaccines Revenue Market Share by Country in 2020
Figure 51. Europe Preventable Vaccines Sales Market Share by Type in 2020
Figure 52. Europe Preventable Vaccines Sales Market Share by Application in 2020
Figure 53. Germany Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Preventable Vaccines Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Preventable Vaccines Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Preventable Vaccines Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Preventable Vaccines Sales Market Share by Application in 2020
Figure 62. Egypt Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Preventable Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


★調査レポート[世界の予防可能ワクチン市場予測 2021年-2026年] (コード：LPI21MY9555)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の予防可能ワクチン市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のB型肝炎ワクチン市場予測 2021年-2026年
    LPI21MY9631 / LP Information / 2021年5月 / LPインフォメーション社の「B型肝炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酵母由来、CHO由来など、用途別には、子供、大人などにセグメント区分してまとめました。B型肝炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・B型肝炎ワクチンの世界市場概要（サマリー） ・B型肝炎ワクチンの企業別販売量・売上 ・B型肝炎ワクチンの企業別市場シェア ・B型肝炎ワクチンの世界市場規模 2016年-2021年：種類別（酵母由来、CHO由来） ・B型肝炎ワクチンの世界市場規模 2016年-2021年：用途別（子供、大人） ・B型肝炎ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・B型肝炎ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Hepatitis B Vaccines will have significant change from previous year. By the most conservative estimates of global Hepatitis B Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 973 million in 2019. Over the next five years the Hepatitis B Vaccines market will register a 1.8% CAGR in terms of revenue, the global market size will reach US$ 1046.9 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccines market by product type,...
  • 世界の商業水産用ワクチン市場予測 2021年-2026年
    LPI21MY9488 / LP Information / 2021年5月 / LPインフォメーション社の「商業水産用ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、核酸ワクチン、サブユニットワクチン、弱毒生ワクチン、不活化ワクチンなど、用途別には、水産、繁殖クリニック、水産研究所などにセグメント区分してまとめました。商業水産用ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・商業水産用ワクチンの世界市場概要（サマリー） ・商業水産用ワクチンの企業別販売量・売上 ・商業水産用ワクチンの企業別市場シェア ・商業水産用ワクチンの世界市場規模 2016年-2021年：種類別（核酸ワクチン、サブユニットワクチン、弱毒生ワクチン、不活化ワクチン） ・商業水産用ワクチンの世界市場規模 2016年-2021年：用途別（水産、繁殖クリニック、水産研究所） ・商業水産用ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・商業水産用ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Commercial Aquaculture Vaccines will have significant change from previous year. By the most conservative estimates of global Commercial Aquaculture Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Commercial Aquaculture Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Commercial Aquaculture Vaccines market by product type,...
  • 世界のDT混合ワクチン市場予測 2021年-2026年
    LPI21MY9514 / LP Information / 2021年5月 / LPインフォメーション社の「DT混合ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、二種類以上疾患から保護、異なる菌株・血清型による疾患から保護など、用途別には、子供、大人、高齢者、妊娠などにセグメント区分してまとめました。DT混合ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・DT混合ワクチンの世界市場概要（サマリー） ・DT混合ワクチンの企業別販売量・売上 ・DT混合ワクチンの企業別市場シェア ・DT混合ワクチンの世界市場規模 2016年-2021年：種類別（二種類以上疾患から保護、異なる菌株・血清型による疾患から保護） ・DT混合ワクチンの世界市場規模 2016年-2021年：用途別（子供、大人、高齢者、妊娠） ・DT混合ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・DT混合ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of DT-Based Combined Vaccines will have significant change from previous year. By the most conservative estimates of global DT-Based Combined Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the DT-Based Combined Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of DT-Based Combined Vaccines market by product type,...
  • 世界の小児用ワクチン市場予測 2021年-2026年
    LPI21MY9617 / LP Information / 2021年5月 / LPインフォメーション社の「小児用ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他など、用途別には、新生児、乳児、子供、青少年などにセグメント区分してまとめました。小児用ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・小児用ワクチンの世界市場概要（サマリー） ・小児用ワクチンの企業別販売量・売上 ・小児用ワクチンの企業別市場シェア ・小児用ワクチンの世界市場規模 2016年-2021年：種類別（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他） ・小児用ワクチンの世界市場規模 2016年-2021年：用途別（新生児、乳児、子供、青少年） ・小児用ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・小児用ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pediatric Vaccines will have significant change from previous year. By the most conservative estimates of global Pediatric Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 28250 million in 2019. Over the next five years the Pediatric Vaccines market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 35510 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Vaccines market by product type, application, key manufacturers and...
  • 世界のPRRSワクチン市場予測 2021年-2026年
    LPI21MY6857 / LP Information / 2021年5月 / LPインフォメーション社の「PRRSワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、生ワクチン、不活化ワクチンなど、用途別には、政府入札、市場販売などにセグメント区分してまとめました。PRRSワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・PRRSワクチンの世界市場概要（サマリー） ・PRRSワクチンの企業別販売量・売上 ・PRRSワクチンの企業別市場シェア ・PRRSワクチンの世界市場規模 2016年-2021年：種類別（生ワクチン、不活化ワクチン） ・PRRSワクチンの世界市場規模 2016年-2021年：用途別（政府入札、市場販売） ・PRRSワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・PRRSワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of PRRS Vaccines will have significant change from previous year. By the most conservative estimates of global PRRS Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the PRRS Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of PRRS Vaccines market by product type, application, key manufacturers and...
  • 世界のエスモロール塩酸塩市場予測 2021年-2026年
    LPI21MY9524 / LP Information / 2021年5月 / LPインフォメーション社の「エスモロール塩酸塩の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、上室性頻脈、術中・術後頻脈、高血圧、非代償性洞性頻脈など、用途別には、病院、クリニック、研究所、その他などにセグメント区分してまとめました。エスモロール塩酸塩のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・エスモロール塩酸塩の世界市場概要（サマリー） ・エスモロール塩酸塩の企業別販売量・売上 ・エスモロール塩酸塩の企業別市場シェア ・エスモロール塩酸塩の世界市場規模 2016年-2021年：種類別（上室性頻脈、術中・術後頻脈、高血圧、非代償性洞性頻脈） ・エスモロール塩酸塩の世界市場規模 2016年-2021年：用途別（病院、クリニック、研究所、その他） ・エスモロール塩酸塩の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・エスモロール塩酸塩のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Esmolol Hydrochloride will have significant change from previous year. By the most conservative estimates of global Esmolol Hydrochloride market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Esmolol Hydrochloride market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Esmolol Hydrochloride market by product type, application, key manufacturers and...
  • 世界のダニ媒介性脳炎ワクチン市場予測 2021年-2026年
    LPI21MY9672 / LP Information / 2021年5月 / LPインフォメーション社の「ダニ媒介性脳炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルスなど、用途別には、小児用ワクチン、成人用ワクチン、旅行者用ワクチンなどにセグメント区分してまとめました。ダニ媒介性脳炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ダニ媒介性脳炎ワクチンの世界市場概要（サマリー） ・ダニ媒介性脳炎ワクチンの企業別販売量・売上 ・ダニ媒介性脳炎ワクチンの企業別市場シェア ・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年：種類別（ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス） ・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年：用途別（小児用ワクチン、成人用ワクチン、旅行者用ワクチン） ・ダニ媒介性脳炎ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ダニ媒介性脳炎ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Tick-borne Encephalitis Vaccine will have significant change from previous year. By the most conservative estimates of global Tick-borne Encephalitis Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Tick-borne Encephalitis Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Tick-borne Encephalitis Vaccine market by product type,...
  • 世界のブルセラアボルタスワクチン市場予測 2021年-2026年
    LPI21MY9458 / LP Information / 2021年5月 / LPインフォメーション社の「ブルセラアボルタスワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、DNAワクチン、サブユニットワクチン、ベクターワクチン、Bアボルタス組換え変異体、その他など、用途別には、牛、羊、豚、その他などにセグメント区分してまとめました。ブルセラアボルタスワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ブルセラアボルタスワクチンの世界市場概要（サマリー） ・ブルセラアボルタスワクチンの企業別販売量・売上 ・ブルセラアボルタスワクチンの企業別市場シェア ・ブルセラアボルタスワクチンの世界市場規模 2016年-2021年：種類別（DNAワクチン、サブユニットワクチン、ベクターワクチン、Bアボルタス組換え変異体、その他） ・ブルセラアボルタスワクチンの世界市場規模 2016年-2021年：用途別（牛、羊、豚、その他） ・ブルセラアボルタスワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ブルセラアボルタスワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Brucella Abortus Vaccine will have significant change from previous year. By the most conservative estimates of global Brucella Abortus Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Brucella Abortus Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Brucella Abortus Vaccine market by product type,...
  • 世界の家禽医療市場予測 2021年-2026年
    LPI21MY9630 / LP Information / 2021年5月 / LPインフォメーション社の「家禽医療の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ワクチン、寄生虫駆除剤、抗感染薬、薬用飼料添加物、その他など、用途別には、農業用、家庭用、その他などにセグメント区分してまとめました。家禽医療のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・家禽医療の世界市場概要（サマリー） ・家禽医療の企業別販売量・売上 ・家禽医療の企業別市場シェア ・家禽医療の世界市場規模 2016年-2021年：種類別（ワクチン、寄生虫駆除剤、抗感染薬、薬用飼料添加物、その他） ・家禽医療の世界市場規模 2016年-2021年：用途別（農業用、家庭用、その他） ・家禽医療の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・家禽医療のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Poultry Health will have significant change from previous year. By the most conservative estimates of global Poultry Health market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 5670 million in 2019. Over the next five years the Poultry Health market will register a 4.5% CAGR in terms of revenue, the global market size will reach US$ 6753.9 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Health market by product type, application, key manufacturers and...
  • 世界の生物学的反応修飾因子市場予測 2021年-2026年
    LPI21MY9446 / LP Information / 2021年5月 / LPインフォメーション社の「生物学的反応修飾因子の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、インターロイキン、インターフェロン、コロニー刺激因子、チロシンキナーゼ阻害剤、TNF-α、血管新生阻害剤、モノクローナル抗体、腫瘍ワクチンなど、用途別には、病院薬局、小売薬局、通信販売薬局などにセグメント区分してまとめました。生物学的反応修飾因子のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・生物学的反応修飾因子の世界市場概要（サマリー） ・生物学的反応修飾因子の企業別販売量・売上 ・生物学的反応修飾因子の企業別市場シェア ・生物学的反応修飾因子の世界市場規模 2016年-2021年：種類別（インターロイキン、インターフェロン、コロニー刺激因子、チロシンキナーゼ阻害剤、TNF-α、血管新生阻害剤、モノクローナル抗体、腫瘍ワクチン） ・生物学的反応修飾因子の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、通信販売薬局） ・生物学的反応修飾因子の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・生物学的反応修飾因子のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Biologic Response Modifiers will have significant change from previous year. By the most conservative estimates of global Biologic Response Modifiers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Biologic Response Modifiers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Response Modifiers market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆